Projects funded by the NCN

Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation...

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr hab. Agata Faron-Górecka

Instytut Farmakologii PAN

Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

Call: OPUS 26 , Panel: NZ7

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

Plasticity of neuroanatomically identified synaptic inputs and functions of the dorsal raphe nucleus in an animal model ...

Call: OPUS 25 , Panel: NZ4

Principal investigator: prof. Krzysztof Tokarski

Instytut Farmakologii PAN

Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br...

Call: SONATA 16 , Panel: NZ7

Principal investigator: dr Katarzyna Elżbieta Głombik

Instytut Farmakologii PAN

Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

Call: OPUS 13 , Panel: NZ7

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

The effects of thyroid hormones in the brain in an animal model of depression

Call: OPUS 13 , Panel: NZ7

Principal investigator: prof. Bogusława Budziszewska

Instytut Farmakologii PAN

Sensitivity to negative feedback as a cognitive biomarker of depression in an animal model

Call: OPUS 12 , Panel: NZ4

Principal investigator: dr hab. Rafał Ryguła

Instytut Farmakologii PAN

The role of microRNA biogenesis system in vulnerability and resilience to stress in an animal model of depression

Call: PRELUDIUM 9 , Panel: NZ4

Principal investigator: Dariusz Marek Żurawek

Instytut Farmakologii PAN

Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress...

Call: PRELUDIUM 9 , Panel: NZ7

Principal investigator: dr Ewa Izabela Trojan

Instytut Farmakologii PAN